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Objective. The study was performed to review the complications of surgery for POP with or without surgery for SUI. This included
the need for second procedure two years after the primary surgery. Study Design. We conducted a retrospective cross-sectional
comparative study at the Aga Khan University, Karachi, Pakistan. International Classification of Diseases, 9th revision, Clinical
Modification (ICD-9-CM) was used to identify women who underwent vaginal hysterectomy with anterior/posterior repair alone
and thosewith concomitant tension-free vaginal tape surgery for urodynamic stress incontinence.Results.The 28 cases ofVH/repair
combined with TVT were compared for complications with 430 cases of VH with repair alone. The basic characteristics like
age, BMI, and degree of prolapse showed no statistical difference among two groups. The main comorbidities in both groups
were hypertension, diabetes, and bronchial asthma. We observed no significant differences in intraoperative and postoperative
complications except for cuff abscess, need for medical intervention, and readmission following discharge from hospital, which
were higher in cases with vaginal hysterectomy with concomitant TVT. Conclusions. Vaginal hysterectomy is an efficient treatment
for uterovaginal prolapse with a swift recovery, short length of hospital stay, and rare serious complications.The addition of surgery
for USI does not appear to increase the morbidity.
1. Introduction
Pelvic organ prolapse (POP) affects millions of women;
approximately 200,000 inpatient surgical procedures for
prolapse are performed annually in the United States [1, 2].
Eleven to 19 percent of women will undergo surgery for
prolapse or incontinence by age 80 to 85 years, and 30 percent
of these women will require an additional prolapse repair
procedure [3, 4]. The prevalence of POP in rural Pakistan is
12.1% and the prevalence of POP with urinary incontinence
(UI) is 12.5% [5].
Pelvic organ prolapse (POP) and stress urinary incon-
tinence (SUI) are common, often coexist, and can greatly
impact quality of life [6]. Population-based studies report an
11–19% percent lifetime risk in women undergoing surgery
for prolapse or incontinence [5, 7]. Recurrence of symptoms
is common, following POP or SUI. Six to twenty-nine
percent of women who undergo pelvic floor repair will
require additional surgery for recurrent prolapse or stress
incontinence [5, 8]. The success observed with the use of
surgical mesh in general surgery, combined with the high
failure rates for traditional colporrhaphy, has led gynecologic
reconstructive surgeons to implement surgical approaches
that utilize reconstructivematerials [9]. According tomedical
device manufacturer estimates, approximately 33 percent
of POP repair procedures and 80 percent of incontinence
procedures utilize reconstructivematerials [10]. During 2008,
NICE guidelines [11] were published regarding surgical repair
of vaginal wall prolapse using mesh. The results of meta-
analysis concluded that mesh seemed to improve objective
outcome for anterior repair, while subjectively there was no
change and, for posterior repair, mesh made no difference.
The same group of consultants published systematic review
regarding efficacy and safety of mesh or grafts in surgery
2 Obstetrics and Gynecology International
for anterior and/or posterior vaginal wall prolapse [12]; the
meta-analysis showed good outcome in terms of recurrence
by the use of nonabsorbable mesh and they concluded
that evidence for most outcomes was too sparse to provide
meaningful recommendations. Recently, Maher et al. [13]
published Cochrane review regarding surgical management
of POP and it revealed that the use of mesh or graft inlays
at the time of anterior vaginal wall repair reduces the risk of
recurrent anterior wall prolapse on examination. The review
includes twenty-one trials that compared a variety of surgical
procedures for anterior compartment prolapse (cystocele).
Ten trials compared native tissue repairwith graft (absorbable
and permanent mesh, biological grafts) repair for anterior
compartment prolapse.Native tissue anterior repair was asso-
ciated with more recurrent anterior compartment prolapse
than when supplemented with a polyglactin (absorbable)
mesh inlay (RR 1.39, 95% CI 1.02 to 1.90) or porcine dermis
mesh inlay (RR 2.08, 95% CI 1.08 to 4.01).
Pakistan is a developing country with limited resources
for the treatment of POP. Even though the Aga Khan
University is a well-equipped tertiary level teaching hospital,
but the percentage of population who can access treatment
in this hospital is very limited. The mesh tools like trocar
guided mesh or mesh fixating kits are not readily available;
few trocar-guided mesh kits are used for stress urinary
incontinence and custom-tailored mesh is used for recurrent
or vault prolapse cases.
In view of serious concerns with the use of mesh, we
planned a retrospective study to review the complications of
simple vaginal hysterectomy (VH) with anterior and poste-
rior repair along with McCall’s culdoplasty for prevention of
vault prolapse and concomitant surgery for SUI.
2. Materials and Methods
We conducted a retrospective cross-sectional comparative
study at the Aga Khan University, Karachi, Pakistan. Interna-
tional Classification of Diseases, 9th revision, Clinical Mod-
ification (ICD-9-CM) procedure codes 68.59 and 59.79 were
used to identifywomenwhounderwent vaginal hysterectomy
with anterior/posterior repair alone and those with con-
comitant tension-free vaginal tape surgery for urodynamic
stress incontinence. ICD-9-CMprocedure codeswere used to
estimate these procedures, from January 2005 till December
2010. At our hospital, standard definition and classification
for the degree of POP and UI is used. We use the Baden-
Walker classification for the gradesof anterior and posterior
vaginal wall and for uterine prolapse; hence, in all cases,
preoperative evaluation was made in clinics using the Baden-
Walker classification for grades of POP and it was further
confirmed under anesthesia. The study was conducted by
reviewing medical records of all the women who underwent
vaginal hysterectomy for pelvic organ prolapse. We assessed
the outcome of VH among two groups, one had simple
VH with anterior and posterior repair (𝑛 = 430), while
the other group had similar surgery along with midurethral
sling operation for SUI (𝑛 = 28) and McCall’s culdoplasty
was routinely performed in all cases for prevention of vault
prolapse.
2.1. Surgical Complications. The following were noted as
intraoperative complications: hemorrhage, urinary bladder,
ureter, and rectal injury.We also included postoperative early
complications, (within 7 days of surgery) prolong length
of stay, unplanned ICU admission, blood transfusion (s),
urinary tract infection, urinary retention, pelvic infection,
nonpelvic infection, deep venous thrombosis (DVT) and
febrile illness. Postoperative delayed complications (between
day 8 and 6 weeks completed) included vaginal vault
hematoma, cuff abscess, readmission, need for laparoscopy,
voiding dysfunction, need for a second procedure for POP,
and medical interventions (including extended antibiotic
usage, use of low molecular heparin, and extended usage of
analgesia). Postoperative delayed complications (between 6
weeks and 2 years completed) included repeat surgery for
POP and/or surgery for SUI.
2.2. Statistical Analysis. Entry of data and analysis was done
using SPSS version 20. Descriptive statistics were computed
for all variables of the study. Comparisons between two
groups were evaluated with Chi-square or Fisher’s exact test
for nominal variables and the 2-sample 𝑡-test. All calculated
𝑃 values were 2 sided, and 𝑃 less than 0.05 was considered
statistically significant.
3. Results
Results showed that there were 28 cases of VH/repair along
with TVT compared to 430 cases of VH with repair. The
incidence of complications in our cohort with uterine pro-
lapsed managed by native tissue repair was low. Table 1
shows patients’ characteristics and preoperative evaluation
of prolapse. Both groups showed no statistical difference in
terms of age and BMI. Vaginal hysterectomy and vaginal
hysterectomy with TVT had no difference in preoperative
evaluation regarding anterior defect and uterine prolapse;
however, posterior defect had statistically significant differ-
ence (𝑃 = 0.046). The medical comorbidity of both groups
is summarized in Table 2. The main comorbidity identified
is hypertension and it is the same in both groups with 𝑃 =
0.635, showing no statistical difference. Diabetes mellitus and
bronchial asthma were other two large comorbidities which
were equal in both groups (𝑃 = 0.116 and 𝑃 = 0.45,
resp.). A total of 68 (63 women with VH and repair and 5
women with VH, repair, and TVT) had history of previous
surgery. This included surgery for POP like a Manchester
repair, anterior and posterior colporrhaphy, surgery for SUI
like a Marshall-Marchetti-Krantz, Burch colposuspension,
the obstetric procedure like cesarean sections.
The American Society of American Society of Anesthesi-
ologists score was also the same in both groups (𝑃 = 0.428).
Table 3 shows intraoperative and postoperative complications
in both groups. We observed that there was no significant
difference in intraoperative and post-operative complica-
tions except for cuff abscess, need for medical intervention,
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Table 1: Characteristics of cases (vaginal hysterectomy with TVT) and controls (vaginal hysterectomy).
Variable (Vaginal hysterectomy)
𝑁 = 430 (93.9%)
(Vaginal hysterectomy with TVT)
𝑁 = 28 (6.1%) 𝑃 value Total
Age (years) 56.0 ± 11.2 47.8 ± 9.3 0.000 458
Body mass index (BMI) 26.4 ± 4.6 28.4 ± 4.6 0.033 458
Preoperative evaluation of prolapse
Anterior defect
Grade 1 139 (32.3 %) 13 (46.4%)
0.168
152 (33%)
Grade 2 124 (28.8%) 4 (6.25%) 128 (28%)
Grade 3 167 (38.8%) 11 (39.2%) 178 (39%)
Posterior defect
Grade 1 137 (31.8%) 15 (53.5%)
0.046
152 (33%)
Grade 2 121 (28.1%) 7 (25%) 128 (28%)
Grade 3 172 (40%) 6 (21.4%) 178 (39%)
Uterine defect
Grade 1 137 (31.8%) 18 (64.2%)
0.001
155 (34%)
Grade 2 114 (26.5%) 7 (25%) 121 (26%)
Grade 3 179 (41.6%) 3 (10.7%) 182 (40%)
and readmission following discharge from hospital, which
were higher in cases with vaginal hysterectomy with con-
comitant TVT (𝑃 values 0.48, 0.001, and 0.001, resp.).
Wedemonstrated excellent prolapse recurrence rateswith
only two women (0.2%) requiring repeat surgery.
4. Discussion
This study highlights that the morbidity of vaginal hysterec-
tomy and repair with or without concomitant surgery for
SUI is very low. Patients referred to our tertiary care center
commonly present with a greater number of clinically impor-
tant comorbid conditions and greater degree of uterovaginal
prolapse. The main findings are the vaginal hysterectomy
performed for vaginal prolapse in routine clinical health care
setting results in short hospital stay, swift recovery, and a
low rate of complications whether performed alone or with
concomitant surgical procedure for SUI. Furthermore, there
is a high success rate in terms of need for a second procedure
and the results are comparable to those of other studies of
vaginal hysterectomy, regardless of indication [5, 14–17].
Our study has some limitations. First, it was inherently
limited by its retrospective nature. Second, therewas a dispar-
ity in number of cases in both groups although some of the
basic demographic characteristics were statistically different,
but these differences were overall clinically similar in both
groups. Third, we examined followup data only through the
2 years of postoperative period and complications like vault
prolapse usually appear late; however, complications due to
surgery should diminish with time.
The strength of the study is that all cases were operated
by experienced gynecologists and medical records included
clear indication types and grades of prolapse. All the cases
with stress urinary incontinence had urodynamic studies to
establish the diagnosis of urodynamic stress incontinence
(USI). Thus, the data used in the current study was without
any greater bias or flaw.
The main comorbidities identified in our study were
hypertension (42%), diabetes mellitus (21%), bronchial
asthma (7.2%), and anemia (7%). Our study participants had
higher frequency of hypertension and diabetes as compared
to the prevalence of type 2 diabetes mellitus in Pakistan as
7–11% [18] and hypertension as 21.5% [19]. A study from
Nepal showed that 35% of women with POP had a chronic
obstructive pulmonary disease (COPD), 16% suffered from
hypertension, and 5% had diabetes mellitus [20]. There was a
history of previous surgery either abdominal or vaginal (15%)
including 5 cases of VH with TVT and 63 cases of VH with
repair, but this did not lead to increased morbidity; in an
Indian study, a similar number of cases (15.2%) had a prior
history of surgery and in one case vaginal hysterectomy route
was changed to abdominal hysterectomy [21]. In another
study from Sweden, conversion to laparotomywas performed
in two cases, one due to complication because of bleeding and
the other because of adhesions, narrow vagina, and immobile
uterus [22]. In the current study, intraoperative hemorrhage
occurred in a total of 19/458 cases; however, there was no
need for reoperation and all these cases required only blood
transfusion. Swedish study showed the need for reoperation
during hospital stay in 1% of patients primarily due to
retroperitoneal and intra-abdominal bleeding [22]. Among
the delayed complications, cuff abscess occurred in 2 cases
of VH with repair and underwent diagnostic laparoscopy.
While in one case of VH with repair and TVT, cuff abscess
was managed conservatively. The prevalence of infections
associatedwith vaginal hysterectomy for POPduring hospital
stay has been estimated at 2% for vaginal infections, 1.3%
for urinary tract infections (UTI), and 0.1% for combined
genitor-urinary infections [22]. Most of our patients received
only preoperative prophylactic antibiotics. Febrile illness was
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Table 2: Comorbidities of cases (vaginal hysterectomy with TVT) and controls (vaginal hysterectomy).
Variable
Controls (vaginal
hysterectomy)
𝑛 = 430
Cases (vaginal
hysterectomy with TVT)
𝑛 = 28
𝑃 value Total
Cardiovascular
Hypertension 180 (41.9%) 13 (46.4%) 0.635 193 (42%)
Cardiovascular disease 13 (3%) 0 (0%) 0.351 13 (3%)
Peripheral vascular disease 2 (0.5%) 0 (0%) 0.7 2 (0%)
Myocardial infarction (history) 1 (0.2%) 0 (0%) 0.798 1 (0%)
Respiratory
Asthma 30 (7%) 3 (10.7%) 0.459 33 (7%)
Obstructive pulmonary disease 1 (0.2%) 0 (0%) 0.798 1 (0%)
Gastrointestinal
Reflux disease 3 (0.7%) 0 (0%) 0.657 3 (1%)
Bowel disorder 1 (0.2%) 0 (0%) — 1 (0%)
Liver disorder 1 (0.2%) 0 (0%) 0.798 1 (0%)
Endocrine
Diabetes mellitus 85 (19.8%) 9 (32.1%) 0.116 94 (21%)
Thyroid disorder 14 (3.3%) 0 (0%) 0.332 14 (3%)
Neurologic cerebrovascular accident 3 (0.7%) 0 (0%) 0.657 3 (1%)
Hematologic anemia (hemoglobin,
<11.0 g/dL) 31 (7.2%) 1 (3.6%) 0.464 32 (7%)
History of previous surgery 63 (14.6%) 5 (17.8%) 0.588 68 (15%)
ASA score
1 or 2 308 (71.6%) 22 (78.6%) 0.428 330 (72%)
3 or 4 122 (28.4%) 6 (21.4%) 128 (28%)
Table 3: Complication of cases (vaginal hysterectomy with TVT) and controls (vaginal hysterectomy).
Variable
Controls (vaginal
hysterectomy)
𝑛 = 430
Cases (vaginal
hysterectomy with TVT)
𝑛 = 28
𝑃value Total (𝑁)
Intraoperative complication
Hemorrhage 18 (4.2%) 1 (3.6%) 0.874 19 (4%)
Urinary bladder injury 1 (0.2%) 0 (0%) 0.798 1 (0%)
Postoperative early complications (within
7 days of surgery)
Prolong length of stay 14 (3.3%) 1 (3.6%) 0.928 15 (3%)
Unplanned ICU admission 4 (0.9%) 0 (0%) 0.608 4 (1%)
Blood transfusion(s) 20 (4.7%) 0 (0%) 0.243 20 (4%)
Urinary tract infection 7 (1.6%) 2 (7.1%) 0.442 9 (2%)
Urinary retention 9 (2.1%) 0 (0%) 0.439 9 (2%)
Pelvic infection 3 (0.7%) 1 (3.6%) 0.113 4 (1%)
Nonpelvic infection 1 (0.2%) 1 (3.6%) 0.009 2 (0%)
Febrile illness 9 (2.1%) 3 (10.7%) 0.006 12 (3%)
Postoperative delayed complications
(between day 8 and 6 weeks)
Cuff abscess 2 (0.5%) 1 (3.6%) 0.048 3 (1%)
Readmission 4 (0.9%) 2 (7.1%) 0.001 6 (1%)
Need for laparoscopy 2 (0.5%) 0 (0%) 0.718 2 (0%)
Medical interventions 4 (0.9%) 2 (7.1%) 0.001 6 (1%)
(between 6 weeks and 2 years ) need for
2nd procedure for POP 2 (0.2%) 0 (0%) 0.718 2 (0%)
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reported as an early complication in 12/458 (2.6%) of total
cases with increasing frequency in both groups (𝑃 = 0.006).
Urinary tract infection was diagnosed in 9 women and in
3 cases there was unspecified infection; however, this led to
prolonged length of stay. The risk of bladder injury during
vaginal hysterectomy has been reported as 13.1 per 1000 [23].
There was one bladder perforation in a case of TVT with an
anticipated risk due to previous Manchester repair, VH, and
Marshall-Marchetti-Krantz operations. Gilmour and Flow-
erdew reported the estimated rate of bladder injury associated
with other gynecologic or urogynecologic surgeries as 11.2 per
1000 surgeries and the rate of ureteral injury as 2.2 per 1000
surgeries [24]. We did not encounter any ureteric injury. The
risk of urinary retention and voiding dysfunction is increased
with concomitant surgery for SUI. In our study, 9 cases had
urinary retention which occurred secondary to urinary tract
and pelvic infection, while transient voiding dysfunctionwith
reduced rate of urinary flow occurred in 2 cases of VH-TVT
group. In a similar comparative study of VH alone and with
TVT, postoperative urinary flowwas found lower in theTVT-
hysterectomy group: 14 versus 24mL/s (𝑃 = 0.02) [25].
Vaginal hysterectomywith repair failed in 2 cases after 12–
18 months of surgery and both presented with vault prolapse.
Both of these cases initially presented with massive vaginal
eversion and refused for vaginal surgery with Mesh. The
second procedure required for correction of vault prolapse
in these two cases was abdominal sacrocolpopexy with
polypropylene mesh and vaginal sacrocolpopexy, respec-
tively. In a retrospective study of 69 patients of vaginal surgery
for POP failed in 17 patients during the follow-up at one
year and they identified overweight/obesity, high parity, and
massive vaginal eversion associated with anatomical and
functional failure after POP repair [26].
5. Conclusion
Vaginal hysterectomy is an excellent treatment option for
uterovaginal prolapse with a swift recovery, shorter length
of hospital stay, and rare serious complications. POP and
USI can both be safely treated by VH and concomitant
surgery for USI. In view of FDA warning for use of mesh,
we need to readdress the efficacy of vaginal hysterectomy
with concomitant surgery for SUI. A larger prospective
randomized trial is required to compare the complication and
surgical outcome of VH for POP.
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